Literature DB >> 31912536

Haemodialysis for lithium poisoning: Translating EXTRIP recommendations into practical guidelines.

Nicholas A Buckley1, Sonia Cheng2,3, Katherine Isoardi4, Angela L Chiew1,2,3, William Siu5, Elia Vecellio6, Betty S Chan2,3.   

Abstract

OBJECTIVES: This study aimed to determine the impact on practice of applying the Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup criteria to lithium toxicity.
METHOD: We retrospectively examined the medical records of patients from three hospitals who presented with chronic or acute on chronic lithium poisoning with a lithium concentration ≥1.3 mmol/L (2008-2018). We determined which criteria were met by patients and their subsequent course. We developed and validated a method to predict if lithium concentration would be >1mmol/L at 36 hours.
RESULTS: There were 111 acute on chronic and 250 chronic lithium toxic patients. Nine patients (2.5%) were treated with haemodialysis. Six chronic patients had neurological sequelae. The "estimated lithium concentration at 36 hours > 1 mmol/L" criterion required pharmacokinetic calculations. A simple nomogram was developed using Estimated Glomerular Filtration Rate (eGFR) and lithium concentration. For chronic toxicity, the nomogram would have correctly predicted lithium concentration >1.4 mmol/L at 36 hours in all except two patients. If EXTRIP criteria were followed, dialysis would have been instituted for 211 patients (58%). However, only 51 patients with chronic toxicity fulfilled both a concentration and a clinical criterion. Late neurological sequelae were observed in five out of six patients who fulfilled a concentration and a clinical criterion on admission, with the sixth meeting these criteria shortly after admission.
CONCLUSIONS: The EXTRIP criteria are too broad, but minor modifications allow haemodialysis to be targeted to those most at risk of sequelae. Most acute on chronic poisonings do not need haemodialysis, but it might shorten hospital stay in those with very high concentrations. The nomogram accurately predicts the fall in lithium concentration for chronic poisoning.
© 2020 The British Pharmacological Society.

Entities:  

Keywords:  EXTRIP; acute on chronic lithium poisoning; chronic lithium toxicity; haemodialysis; nomogram

Mesh:

Substances:

Year:  2020        PMID: 31912536      PMCID: PMC7163377          DOI: 10.1111/bcp.14212

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

Review 1.  Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Brian S Decker; David S Goldfarb; Paul I Dargan; Marjorie Friesen; Sophie Gosselin; Robert S Hoffman; Valéry Lavergne; Thomas D Nolin; Marc Ghannoum
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-12       Impact factor: 8.237

2.  Comparison of patients hemodialyzed for lithium poisoning and those for whom dialysis was recommended by PCC but not done: what lesson can we learn?

Authors:  B Bailey; M McGuigan
Journal:  Clin Nephrol       Date:  2000-11       Impact factor: 0.975

3.  Haemodialysis for lithium poisoning: Translating EXTRIP recommendations into practical guidelines.

Authors:  Nicholas A Buckley; Sonia Cheng; Katherine Isoardi; Angela L Chiew; William Siu; Elia Vecellio; Betty S Chan
Journal:  Br J Clin Pharmacol       Date:  2020-02-11       Impact factor: 4.335

4.  Lithium toxicity: an iatrogenic problem in susceptible individuals.

Authors:  P W Oakley; I M Whyte; G L Carter
Journal:  Aust N Z J Psychiatry       Date:  2001-12       Impact factor: 5.744

5.  Duration of lithium treatment and brain lithium concentration in patients with unipolar and schizoaffective disorder--a study with magnetic resonance spectroscopy.

Authors:  U Riedl; A Barocka; H Kolem; J Demling; W P Kaschka; R Schelp; M Stemmler; D Ebert
Journal:  Biol Psychiatry       Date:  1997-04-15       Impact factor: 13.382

Review 6.  Lithium intoxication. (Report of 23 cases and review of 100 cases from the literature).

Authors:  H E Hansen; A Amdisen
Journal:  Q J Med       Date:  1978-04

7.  Lithium poisoning in the intensive care unit: predictive factors of severity and indications for extracorporeal toxin removal to improve outcome.

Authors:  Dominique Vodovar; Souleiman El Balkhi; Emmanuel Curis; Nicolas Deye; Bruno Mégarbane
Journal:  Clin Toxicol (Phila)       Date:  2016-06-02       Impact factor: 4.467

8.  Pattern of lithium exposure predicts poisoning severity: evaluation of referrals to a regional poisons unit.

Authors:  W S Waring; W J Laing; A M Good; D N Bateman
Journal:  QJM       Date:  2007-04-05

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

  9 in total
  4 in total

1.  Evidence-based recommendations for haemodialysis in lithium-poisoned patients: Getting from where we are to where we want to be.

Authors:  Robert S Hoffman
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

2.  Haemodialysis for lithium poisoning: Translating EXTRIP recommendations into practical guidelines.

Authors:  Nicholas A Buckley; Sonia Cheng; Katherine Isoardi; Angela L Chiew; William Siu; Elia Vecellio; Betty S Chan
Journal:  Br J Clin Pharmacol       Date:  2020-02-11       Impact factor: 4.335

3.  Identifying lithium-poisoned patients who may benefit from haemodialysis remains highly challenging.

Authors:  Dominique Vodovar; Minh P Lê; Laurence Labat; Bruno Mégarbane
Journal:  Br J Clin Pharmacol       Date:  2020-06-02       Impact factor: 4.335

4.  Hemodialysis Treatment for Patients with Lithium Poisoning.

Authors:  Yu-Hsin Liu; Kai-Fan Tsai; Pai-Chin Hsu; Meng-Hsuan Hsieh; Jen-Fen Fu; I-Kuan Wang; Shou-Hsuan Liu; Cheng-Hao Weng; Wen-Hung Huang; Ching-Wei Hsu; Tzung-Hai Yen
Journal:  Int J Environ Res Public Health       Date:  2022-08-15       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.